<https://rdf.molmedb.upol.cz/reference/ref2479> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00085>,
		<https://identifiers.org/molmedb/MM472009>;
	<http://purl.org/ontology/bibo/pmid> "28554092"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM472008>,
		<https://rdf.molmedb.upol.cz/interaction/membrane23>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.ejmech.2017.05.042"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00662>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method30>;
	<http://purl.org/dc/terms/bibliographicCitation> "Xu XL, Yang YR, Mo XF, Wei JL, Zhang XJ, You QD.: Design, synthesis, and evaluation of benzofuran derivatives as novel anti-pancreatic carcinoma agents via interfering the hypoxia environment by targeting HIF-1α pathway. Eur J Med Chem, Volume 137, 2017"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/interaction/int983666> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2479> .
<https://rdf.molmedb.upol.cz/interaction/int983667> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2479> .
<https://rdf.molmedb.upol.cz/interaction/int983623> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2479> .
<https://rdf.molmedb.upol.cz/interaction/int983670> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2479> .